Tag: Clint Sharples
-
Heritage Cannabis (CANN.C) launches new consumer product as global cannabis stocks rally 61% in Q4, 2020
CANN focuses on extraction and the creation of derivative products for recreational and medical consumers.
-
Heritage Cannabis (CANN.C) granted oil sales licence – CannaCure’s Fort Erie facility in focus
CannaCure’s goal is “to transform the global marijuana landscape through innovative growth strategies and strategic partnerships with manufacturers of cannabis products.”
-
Heritage Cannabis (CANN.C) is so close profitability, it’s breaking social distancing rules
Sharples believes that Purefarma, Pura Vida, new contract manufacturing agreements, expansion of Canadian territories, the edibles product launch and the acquisition of Opticann expanding CANN’s U.S. presence will accelerate revenue going forward.
-
Heritage Cannabis (CANN.C) to develop vape oil with Sugarbud’s biomass
Heritage is positioning itself to radically expand its sales territory.
-
Heritage Cannabis (CANN.C) releases Q2, 2020 financials
Gross revenue was $1.4-million in the second quarter of 2020, compared with nil in the three-month period ended April 30, 2019.
-
Heritage Cannabis (CANN.C) launches branded products
Growing cannabis revenues, shrinking losses, a healthy balance sheet – and now a pathway to selling branded extraction products into the Canadian market.
-
Heritage Cannabis (CANN.C) signs monster deal with Cronos (CRON.T)
On July 25, 2019 Heritage Cannabis (CANN.C) announced a vape-device deal with the $6.6 billion Cronos Group (CRON.T). Heritage will fill and package vaporizer devices for the Canadian rec and medical markets. Specifically, vape fulfillment for the Spinach and PEACE NATURALS brands, “utilizing multiple unique and proprietary formulations provided by Cronos Group.” The deal has…